store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SAR131675 是一种选择性的VEGFR3抑制剂,其IC50=23 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 289 | 现货 | ||
5 mg | ¥ 667 | 现货 | ||
10 mg | ¥ 980 | 现货 | ||
25 mg | ¥ 1,870 | 现货 | ||
50 mg | ¥ 3,520 | 现货 | ||
100 mg | ¥ 4,150 | 现货 | ||
200 mg | ¥ 5,920 | 现货 | ||
500 mg | ¥ 8,990 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 612 | 现货 |
产品描述 | SAR131675 is a potent and selective VEGFR3 inhibitor with an IC50 of 23 nM. |
靶点活性 | VEGFR3:23 nM |
体外活性 | KU-0060648 exhibits differential effects on growth inhibition, but is not profoundly cytotoxic in a panel of human cancer cell lines. It inhibits DNA-PK and PI-3K with greater potency in MCF7 than SW620 cell using cell-based assays. Five-day exposure to 1 mM KU-0060648 inhibits cell proliferation by more than 95% in MCF7 cells but only by 55% in SW620 cells. In clonogenic survival assays, KU-0060648 increases the cytotoxicity of etoposide and doxorubicin across the panel of DNA-PKcs-proficient cells, but not in DNA-PKcs-deficient cells, confirming that enhanced cytotoxicity of the topoisomerase II poisons etoposide and doxorubicin is due to DNA-PK inhibition. [1] |
别名 | SAR 131675 |
分子量 | 358.39 |
分子式 | C18H22N4O4 |
CAS No. | 1433953-83-3 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 16.67 mg/mL (46.51 mM), when pH is adjusted to 2 with HCl. Sonification is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7903 mL | 13.9513 mL | 27.9026 mL | 69.7564 mL |
5 mM | 0.5581 mL | 2.7903 mL | 5.5805 mL | 13.9513 mL | |
10 mM | 0.279 mL | 1.3951 mL | 2.7903 mL | 6.9756 mL | |
20 mM | 0.1395 mL | 0.6976 mL | 1.3951 mL | 3.4878 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SAR131675 1433953-83-3 Angiogenesis Tyrosine Kinase/Adaptors VEGFR SAR 131675 Inhibitor Vascular endothelial growth factor receptor SAR-131675 inhibit inhibitor